Prognosis: Breakthrough

The Race Gap in Clinical Trials

Prognosis: Breakthrough

In the rush to develop a vaccine or treatment for Covid-19, drug companies are fast-tracking clinical trials. But those trials have a major diversity problem. Participants in major drug trials range from 70 percent to 89 percent white. This is a big problem, considering it’s a disease that disproportionately affects people of color. Kristen V. Brown reports that failing to account for minority groups could potentially impact how well a drug eventually works for those that the virus has harmed the most. Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

Next Episodes

Prognosis: Breakthrough

The Cost of Keeping Schools Safe @ Prognosis: Breakthrough

πŸ“† 2020-08-10 23:54 / βŒ› 00:13:50


Prognosis: Breakthrough

A Generation of Health Damage @ Prognosis: Breakthrough

πŸ“† 2020-08-07 22:34 / βŒ› 00:16:07


Prognosis: Breakthrough

Will Kids Spread COVID to Teachers? @ Prognosis: Breakthrough

πŸ“† 2020-08-05 23:37 / βŒ› 00:16:54


Prognosis: Breakthrough

The Promise of a New Treatment @ Prognosis: Breakthrough

πŸ“† 2020-08-03 21:37 / βŒ› 00:14:02


Prognosis: Breakthrough

What We Know About Immunity @ Prognosis: Breakthrough

πŸ“† 2020-07-31 22:25 / βŒ› 00:13:29